HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liliana Soroceanu Selected Research

Ligands

1/2023Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment.
12/2007Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liliana Soroceanu Research Topics

Disease

30Neoplasms (Cancer)
03/2024 - 01/2002
12Glioblastoma (Glioblastoma Multiforme)
01/2023 - 02/2007
9Glioma (Gliomas)
11/2016 - 01/2002
6Melanoma (Melanoma, Malignant)
01/2022 - 02/2015
6Infections
01/2014 - 12/2007
3Cholangiocarcinoma
03/2024 - 10/2020
3Brain Neoplasms (Brain Tumor)
01/2023 - 05/2012
2Neoplasm Metastasis (Metastasis)
06/2015 - 01/2002
2Virus Diseases (Viral Diseases)
12/2013 - 02/2008
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2024
1Genomic Instability
08/2021
1Cutaneous Malignant Melanoma
01/2021
1Deficiency Diseases (Deficiency Disease)
11/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Lung Neoplasms (Lung Cancer)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2018
1Pain (Aches)
06/2015
1Nausea
06/2015
1Vomiting
06/2015
1Disease Progression
05/2012
1Inflammation (Inflammations)
11/2011

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2007
6DNA (Deoxyribonucleic Acid)IBA
11/2022 - 03/2006
4Antineoplastic Agents (Antineoplastics)IBA
01/2023 - 12/2013
3Phosphotransferases (Kinase)IBA
03/2024 - 12/2007
3CannabidiolIBA
01/2022 - 03/2013
3CannabinoidsIBA
01/2022 - 06/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 01/2002
3Viral ProteinsIBA
02/2014 - 01/2013
2Biomarkers (Surrogate Marker)IBA
01/2023 - 02/2015
2LigandsIBA
01/2023 - 12/2007
2Mitogen-Activated Protein KinasesIBA
01/2023 - 01/2022
2ErbB Receptors (EGF Receptor)IBA
01/2023 - 02/2007
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022 - 01/2020
2GemcitabineFDA Link
08/2021 - 10/2020
2Poly(ADP-ribose) Polymerase InhibitorsIBA
08/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2019
22- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
01/2020 - 01/2018
2Focal Adhesion Protein-Tyrosine KinasesIBA
01/2020 - 12/2007
2IntegrinsIBA
01/2020 - 12/2007
2Glycoproteins (Glycoprotein)IBA
02/2014 - 12/2007
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2008 - 02/2007
1Tyrosine Kinase InhibitorsIBA
03/2024
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2024
1PeriostinIBA
01/2023
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2023
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2023
1ChemokinesIBA
01/2023
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2023
1sapanisertibIBA
01/2023
1TOR Serine-Threonine KinasesIBA
01/2023
1Circulating Tumor DNAIBA
11/2022
1Cell-Free Nucleic AcidsIBA
11/2022
1bromosporineIBA
01/2022
1cobimetinibIBA
01/2022
1Temozolomide (Temodar)FDA LinkGeneric
01/2022
1Alkylating AgentsIBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1AcidsIBA
08/2021
1DeoxyribonucleotidesIBA
08/2021
1niraparibIBA
08/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021
1dinaciclibIBA
10/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2020
1Complementary DNA (cDNA)IBA
01/2020
1TalinIBA
01/2020
1VinculinIBA
01/2020
1PaxillinIBA
01/2020
1Drug CombinationsIBA
01/2020
1MicroRNAs (MicroRNA)IBA
08/2019
1Cyclin D1IBA
01/2018
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2017
1CPT417IBA
11/2016
1CamptothecinIBA
11/2016
1NestinIBA
08/2015
1cytomegalovirus immediate-early proteinsIBA
08/2015
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2015
1Dronabinol (THC)FDA LinkGeneric
06/2015
1CB2 Cannabinoid ReceptorIBA
06/2015
1fetal Alzheimer antigenIBA
02/2015
1Small Interfering RNA (siRNA)IBA
02/2015
1Neutralizing AntibodiesIBA
02/2014
1matrigelIBA
02/2014
1Interleukin-6 (Interleukin 6)IBA
01/2014
1NucleosidesIBA
12/2013
1Antiviral Agents (Antivirals)IBA
12/2013
1Cidofovir (Vistide)FDA Link
12/2013
1Therapeutic UsesIBA
12/2013
1Stem Cell FactorIBA
01/2013
1GlycosyltransferasesIBA
05/2012
1Laminin (Merosin)IBA
05/2012
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2011
1Platelet-Derived Growth Factor alpha ReceptorIBA
09/2008

Therapy/Procedure

11Therapeutics
01/2024 - 09/2008
2Precision Medicine
01/2023 - 11/2022
2Drug Therapy (Chemotherapy)
10/2020 - 06/2015
1Immunotherapy
01/2022
1Self Medication
01/2021
1Radiotherapy
12/2013